Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan's Job Cuts, Teva Turnaround, Biogen's Cash, And Getting FDA-Friendly

Executive Summary

Daily round-up of news and notes from the 2018 J.P. Morgan Healthcare Conference in San Francisco: US corporate tax reform becomes a reality, Allergan's Saunders defends patent moves as a means of protecting jobs, clarity on generic prices from Teva, Biogen's money to burn, and making the most of FDA flexibility.

Advertisement

Related Content

Pharma Q4 Results Preview: J&J, Novartis, Celgene, Biogen & AbbVie
Allergan Relying On 'Six Stars' And Other R&D Programs To Blunt Restasis Blow
Mohawk Tribe Questions Patent Board's Impartiality In Restasis Case
Schultz Swings The Cleaver At Teva, Cutting 25% Of The Workforce
Q&A With US FDA Commissioner Scott Gottlieb
Allergan Readies Cost Cuts As Restasis Generics Approach
Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents
Too Bold By Half: Allergan’s Latest Moves And Pharma’s Leadership Deficit
Allergan Shifts Restasis Patents To Native American Tribe To Invoke Immunity From IPR
Biogen Builds Out Neuroscience Niche With Ischemic Stroke Drug

Topics

Related Companies

More In

Spotlight On J.P. Morgan Healthcare Conference

Advertisement
UsernamePublicRestriction

Register

SC100167

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel